Sangamo Therapeutics

IPO

Sangamo Therapeutics, Inc. | Pioneering Genetic Cures

Public · Brisbane, United States · Founded 1995 · $168.5M raised

Employees
201–500
Founded
1995
Business Model
B2B
Total Funding
$168.5M
Last Round
$25.0M Corporate RoundDec 2025
Rounds
5
Type
Public

About

Sangamo Therapeutics is a genomic medicine company that translates ground-breaking science into medicines for patients with severe genetic diseases. Using proprietary zinc finger protein technology, modular integrase systems, and gene delivery platforms, the company pursues potential genomic cures across rare disease areas including neurology, hematology, and metabolic disorders. Sangamo collaborates with major pharmaceutical partners to advance its clinical pipeline addressing conditions such as Fabry disease, hemophilia A, and small fiber neuropathy.

Summary

Sangamo Therapeutics is a Biotech company based in Brisbane, United States, founded in 1995. It has raised $168.5M in total across 5 rounds, most recently a $25.0M Corporate Round round in Dec 2025.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundDec 2025
$25.0M

Sign up to see all 6 rounds

Series C through Corporate Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sangamo Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sangamo-therapeutics"><img src="https://indexed.vc/api/badge/company/sangamo-therapeutics" alt="Sangamo Therapeutics on Indexed.vc" width="260" height="76" /></a>